As of 2025-10-17, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (78.22) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.53 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -406.4%.
The range of the Relative Valuation is (78.50) - (82.65) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 14.7x | 13.5x |
| Forward P/E multiples | 14.0x - 19.7x | 14.4x |
| Fair Price | (78.50) - (82.65) | (78.22) |
| Upside | -407.5% - -423.7% | -406.4% |
| Date | P/E |
| 2025-10-16 | -4.55 |
| 2025-10-15 | -4.57 |
| 2025-10-14 | -4.56 |
| 2025-10-13 | -4.55 |
| 2025-10-10 | -4.52 |
| 2025-10-09 | -4.55 |
| 2025-10-08 | -4.57 |
| 2025-10-07 | -4.58 |
| 2025-10-06 | -4.58 |
| 2025-10-03 | -4.58 |
| 2025-10-02 | -4.58 |
| 2025-10-01 | -4.58 |
| 2025-09-30 | -4.57 |
| 2025-09-29 | -4.57 |
| 2025-09-26 | -4.57 |
| 2025-09-25 | -4.56 |
| 2025-09-24 | -4.57 |
| 2025-09-23 | -4.58 |
| 2025-09-22 | -4.58 |
| 2025-09-19 | -4.57 |
| 2025-09-18 | -4.57 |
| 2025-09-17 | -4.56 |
| 2025-09-16 | -4.57 |
| 2025-09-15 | -4.57 |
| 2025-09-12 | -4.56 |
| 2025-09-11 | -4.56 |
| 2025-09-10 | -4.54 |
| 2025-09-09 | -4.54 |
| 2025-09-08 | -4.54 |
| 2025-09-05 | -4.54 |
| 2025-09-04 | -4.54 |
| 2025-09-03 | -4.52 |
| 2025-09-02 | -4.50 |
| 2025-08-29 | -4.52 |
| 2025-08-28 | -4.52 |
| 2025-08-27 | -4.52 |
| 2025-08-26 | -4.52 |
| 2025-08-25 | -4.51 |
| 2025-08-22 | -4.51 |
| 2025-08-21 | -4.50 |
| 2025-08-20 | -4.51 |
| 2025-08-19 | -4.51 |
| 2025-08-18 | -4.51 |
| 2025-08-15 | -4.51 |
| 2025-08-14 | -4.51 |
| 2025-08-13 | -4.52 |
| 2025-08-12 | -4.51 |
| 2025-08-11 | -4.50 |
| 2025-08-08 | -4.50 |
| 2025-08-07 | -4.49 |